Advance Stroke Drug Development through ADME/DMPK Study
Ace Therapeutics, one of the leading preclinical CRO companies for stroke, is excited to announce the expansion of its services with the addition of ADME/DMPK services to support stroke drug development. Drug metabolism and pharmacokinetics (DMPK) play a crucial role in the drug development process for stroke. DMPK studies involve the evaluation of how…
marinabarrow
The Role of Cardiac Organoid Models in Cardiovascular Health
Cardiovascular diseases are the world’s predominant cause of mortality, necessitating novel research tools to expedite both drug discovery and therapeutic development. Traditional in vitro modelling cannot effectively replicate human cardiac tissue, providing unreliable data and extending research lead time. Ace Therapeutics redefines cardiovascular research with breakthrough cardiac organoid model technology that enables unprecedented accuracy, scalability, and physiological relevance…